四川美豐(000731.SZ):車用尿素產銷情況符合年度預期目標
格隆匯12月13日丨四川美豐(000731.SZ)在投資者互動平台表示,車用尿素是一種能有效降低柴油發動機尾氣污染物排放的環保產品,公司在生產過程中秉持工匠精神,追求卓越品質,現已形成車用、船用、脱硝用、工程機械用尿素的美豐加藍品牌矩陣,並向雪龍2號極地科考船供應高品質船用尿素溶液;負責公司環保產品銷售運營的全資子公司-四川美豐加藍環保科技有限責任公司成立10年來,通過深耕市場,逐步建設遍佈全國主要市場的美豐加藍車用尿素智能加註站網絡,探索實踐提供優質高效綠色氮氧化物節能減排的“美豐方案”,先後榮獲“中國十大車用尿素品牌”“卡車兄弟信賴產品”等稱號,並參與車用尿素國家標準起草。2023年,美豐加藍按照年度營銷工作計劃,強化品牌建設,深耕渠道開發,車用尿素產銷情況符合年度預期目標。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.